机构:[1]Institute of Basic Medical Sciences of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing Key Laboratory of Chinese Materia Pharmacology, National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases, Beijing (100091), China[2]Institute of Chinese Medicine Sciences, Guangdong Pharmaceutical University, Guangzhou (510006), China
Supported by the National Natural Science Foundation of China
(No. 82174015 and No. 82030124), Scientific and Technological
Innovation Project of China Academy of Chinese Medical Sciences
(No. CI2021A04609)
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区医学
小类|3 区全科医学与补充医学
最新[2025]版:
大类|4 区医学
小类|4 区全科医学与补充医学
第一作者:
第一作者机构:[1]Institute of Basic Medical Sciences of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing Key Laboratory of Chinese Materia Pharmacology, National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases, Beijing (100091), China[2]Institute of Chinese Medicine Sciences, Guangdong Pharmaceutical University, Guangzhou (510006), China
通讯作者:
通讯机构:[1]Institute of Basic Medical Sciences of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing Key Laboratory of Chinese Materia Pharmacology, National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases, Beijing (100091), China[2]Institute of Chinese Medicine Sciences, Guangdong Pharmaceutical University, Guangzhou (510006), China
推荐引用方式(GB/T 7714):
Cao Ce,Qi Yu-Tong,Wang Ao-Ao,et al.Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway[J].Chinese Journal of Integrative Medicine.2023,doi:10.1007/s11655-023-3640-1.
APA:
Cao Ce,Qi Yu-Tong,Wang Ao-Ao,Wang Zi-Yan,Liu Zi-Xin...&Liu Jian-Xun.(2023).Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway.Chinese Journal of Integrative Medicine,,
MLA:
Cao Ce,et al."Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway".Chinese Journal of Integrative Medicine .(2023)